Global Lyme Disease Diagnostics Market to Gain CAGR of 4.8% From 2023- 2031

HOUSTON, TEXAS, UNITED STATES, July 13, 2023/EINPresswire.com/ -- Lyme disease has been on the rise in many parts of the world, particularly in North America, Europe, and parts of Asia. Factors contributing to the increasing prevalence include expanding tick populations, changing climate patterns and increased human exposure to tick habitats. This rising prevalence of Lyme disease highlights the need for effective diagnostics, treatment, and prevention strategies. Healthcare systems and facilities are adapting to manage the growing burden of Lyme disease by enhancing their diagnostic capabilities, increasing awareness among healthcare professionals, and investing in research and development.

Get PDF sample report with related graphs & charts (Pre & post COVID-19 impact analysis): https://www.absolutemarketsinsights.com/request_sample.php?id=1575

The North American region, particularly the United States, has a significant impact on the global lyme disease diagnostics market. Lyme disease diagnosis alone in rural areas in the U.S. has rose by 35% whereas in the urban areas it has spiked upto 65% during the past few years. Recent data gathered by Absolute Markets Insights suggest that approximately 476,000 people may get affected by lyme disease each year in the United States. The region with the highest prevalence of Lyme disease is considered to be North America, specifically the northeastern and mid-Atlantic regions of the United States. Lyme disease is endemic in these areas, particularly in states such as Connecticut, New York, Pennsylvania, and New Jersey. These regions have a higher concentration of black-legged ticks (deer ticks) that carry the Borrelia burgdorferi bacteria, which causes Lyme disease. A few trends owing to which the North American region holds a dominant position in 2022 across the lyme disease diagnostics market are listed below:

Speak to our analyst in case of queries before buying this report: https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=1575

Improved Testing Technologies: The North American market has witnessed advancements in Lyme disease diagnostic tests, including PCR-based tests, improved serological assays, and point-of-care testing options. These advancements aim to enhance accuracy, sensitivity, and specificity, leading to better detection and diagnosis of Lyme disease.

• Awareness and Screening Programs: There has been an increased emphasis on raising awareness about Lyme disease in North America, both among healthcare professionals and the general public. This awareness has led to proactive screening programs, early detection, and timely treatment, contributing to the growth of the lyme disease diagnostics market.
• Regulatory Environment: The regulatory landscape in North America, particularly in the United States, plays a crucial role in shaping the Lyme disease diagnostics market. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) provide guidelines for the development and approval of diagnostic tests, ensuring their safety and effectiveness.
• Research and Development: North America is a hub for research and development activities related to Lyme disease diagnostics. Academic institutions, government agencies, and private organizations invest in research to improve diagnostic techniques, develop new tests, and explore innovative approaches to Lyme disease detection.
• Collaboration and Partnerships: Collaboration between diagnostic test manufacturers, healthcare institutions, and research organizations is common in North America. These partnerships aim to enhance the availability, accessibility, and quality of Lyme disease diagnostic tests, contributing for overall market growth.
• Point-of-Care Testing: The demand for point-of-care testing for Lyme disease is rising in North America. Point-of-care tests provide rapid results, allowing for immediate diagnosis and timely treatment decisions, particularly in regions with a high prevalence of Lyme disease.

View our exclusive press releases on Industry Global News24

Global Lyme Disease Diagnostics Market Players
o Bio-Rad Laboratories
o Cenogenics Corporation
o Ceres Nanosciences Inc.
o Galaxy Diagnostics
o IGeneX Inc
o Lyme Diagnostics Ltd.
o Oxford Immunotec USA Inc.
o PerkinElmer Genomics
o QIAGEN
o Quest Diagnostics Incorporated.
o T2 Biosystems Inc.
o Thermo Fisher Scientific, Inc.
o Trinity Biotech
o Other Industry Participants

Purchase the latest in-depth Global Lyme Disease Diagnostics Market Report: https://www.absolutemarketsinsights.com/checkout?id=1575

Global Lyme Disease Diagnostics Market:

By Diagnostic Test
o Direct Detection test
 Culture
 Polymerase Chain Reaction (PCR) Testing
 Antigen Detection
o Indirect Detection Test
 ELISA
 Western Blot
 Immunofluorescence (IFA)
 Immunoblot
o Cerebrospinal Fluid Tests
o Brain Imaging
 Magnetic Resonance Imaging
 SPECT Imaging
 PET Imaging
o Neuropsychological Testing
o Others
By Stages
o Early localized Lyme
o Early disseminated Lyme
o Late disseminated Lyme
By Sample
o Blood
o Cerebrospinal Fluid (CSF)
o Urine
o Serum
o Others
By End User
o Hospitals and Clinics
o Specialty Clinics
o Clinical Laboratories

Request for customization to meet your precise research requirements: https://www.absolutemarketsinsights.com/request_for_customization.php?id=1575

By Region
o North America (U.S., Canada, Mexico, Rest of North America)
o Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
o Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
o Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
o Latin America (Brazil, Argentina, Rest of Latin America)

Top Reports
1. Global X-Ray CsI Scintillator Market
2. Global Antisense and RNAi Therapeutics Market

About Us:
Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.

Contact Us:
Contact Name: Shreyas Tanna
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: +1-510-420-1213
Website: www.absolutemarketsinsights.com

Shreyas Tanna
Absolute Markets Insights
+1 510-420-1213
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.